Leriva announces the launch of Antimetil®, a concentrated standardized ginger extract that combats nausea and vomiting.

Leriva announces the launch of Flexofytol®, a patented dietary supplement that supports the flexibility of joints, muscles, and tendons
28 September 2020
Panaxia and Leriva announce exclusive collaboration in the medical cannabis field
19 May 2021
Athens, October 22, 2020 – Leriva announces the launch of Antimetil®, a concentrated standardized ginger extract that combats nausea and vomiting.

Developed by Tilman, the internationally renowned specialist in phytotherapy, the Antimetil® formulation contains a ginger extract that is 10 times more concentrated than traditional ginger powder and it is scientifically derived to help in the symptoms of all types of nausea. The standardization of the ginger extract ensures consistent quality, accurate dosage, and safe use. The efficacy of ginger in reducing temporary digestive discomforts and aiding in the maintenance of optimal digestive balance without causing adverse effects, has been demonstrated in numerous studies. To address digestive well-being, Antimetil® can be used in cases of overeating, during periods when usual eating habits are disrupted, during pregnancy and when travelling. Antimetil® is suitable for the entire family and in addition to pregnant women, can also be taken by children aged 6 or above.

Available in packs of 36, each box of Antimetil® contains two blister sheets of 18 film-coated tablets. Antimetil® is natural, non-GMO, has no known side effects or medication interactions, and is proven to be safe and effective for daily use.

About Leriva

Based in Athens, Greece, Leriva is a diversified health care enterprise that is constituted of four legal entities and conducts operations through several business units. Through its various business units, Leriva distributes and markets a broad range of health care products and services. With an impressive array of business collaborations and alliances with both established and emerging companies that are at the forefront of innovation with novel products and services, Leriva is active in numerous health care market segments and product categories. Leriva’s customer roster includes public and private hospitals, outpatient diagnostic centers and laboratories, industrial companies, research institutes, pharmaceutical wholesalers and pharmacies.

Positioned behind the pharmacy channel and driven by the overriding theme Science You Can Trust, which conveys the scientifically-backed efficacy and uniqueness of its products, Leriva’s Consumer Health Care business unit (a division of Leriva Pharma SA) markets innovative dietary supplements and consumer medical devices that help consumers improve their health and enhance personal wellbeing.

About Tilman

Based in Belgium, Tilman manufactures and markets an extensive range of medicines and food supplements that offer natural herbal solutions and are designed to improve daily life with clinically proven efficacy. As the leader in the field of medicinal plants in Belgium, Tilman is widely recognized internationally as a specialist in phytotherapy and the company’s products are marketed in more than 30 countries. The Tilman products are manufactured in Belgium in GMP (Good Manufacturing Practices) facilities and are only available in pharmacies where health care professionals are present to advise and guide the patient's choice.